1. Home
  2. NRXP vs SOTK Comparison

NRXP vs SOTK Comparison

Compare NRXP & SOTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • SOTK
  • Stock Information
  • Founded
  • NRXP 2015
  • SOTK 1975
  • Country
  • NRXP United States
  • SOTK United States
  • Employees
  • NRXP N/A
  • SOTK N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • SOTK Industrial Machinery/Components
  • Sector
  • NRXP Health Care
  • SOTK Technology
  • Exchange
  • NRXP Nasdaq
  • SOTK Nasdaq
  • Market Cap
  • NRXP 58.5M
  • SOTK 52.1M
  • IPO Year
  • NRXP N/A
  • SOTK 1987
  • Fundamental
  • Price
  • NRXP $2.89
  • SOTK $3.30
  • Analyst Decision
  • NRXP Strong Buy
  • SOTK Hold
  • Analyst Count
  • NRXP 4
  • SOTK 1
  • Target Price
  • NRXP $28.50
  • SOTK N/A
  • AVG Volume (30 Days)
  • NRXP 283.3K
  • SOTK 6.9K
  • Earning Date
  • NRXP 08-19-2025
  • SOTK 10-14-2025
  • Dividend Yield
  • NRXP N/A
  • SOTK N/A
  • EPS Growth
  • NRXP N/A
  • SOTK N/A
  • EPS
  • NRXP N/A
  • SOTK 0.09
  • Revenue
  • NRXP N/A
  • SOTK $20,606,116.00
  • Revenue This Year
  • NRXP N/A
  • SOTK N/A
  • Revenue Next Year
  • NRXP $230.95
  • SOTK $7.13
  • P/E Ratio
  • NRXP N/A
  • SOTK $36.67
  • Revenue Growth
  • NRXP N/A
  • SOTK N/A
  • 52 Week Low
  • NRXP $1.10
  • SOTK $3.23
  • 52 Week High
  • NRXP $6.01
  • SOTK $6.05
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 54.48
  • SOTK 41.18
  • Support Level
  • NRXP $2.30
  • SOTK $3.25
  • Resistance Level
  • NRXP $2.68
  • SOTK $3.38
  • Average True Range (ATR)
  • NRXP 0.19
  • SOTK 0.09
  • MACD
  • NRXP 0.02
  • SOTK 0.01
  • Stochastic Oscillator
  • NRXP 89.39
  • SOTK 41.29

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About SOTK Sono-Tek Corporation

Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

Share on Social Networks: